Study Suggests Presence of AML Mutations at Remission Heralds Relapse Risk | GenomeWeb

NEW YORK (GenomeWeb) – The proportion of bone marrow cells harboring leukemia-related mutations during acute myeloid leukemia remission can provide a window into relapse risk, according to a study published online today in the Journal of the American Medical Association.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Dec
08
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss the application of circulating tumor DNA (ctDNA) sequencing to evaluate the emergence of resistance mutations during therapy.